US Stocks
/
Citius Pharmaceuticals, Inc. Share Price

Citius Pharmaceuticals, Inc. Share Price

NASDAQ: CTXR
$0.68
+$0.00 (0.18%) Last updated on 10 Aug, 2026 | 21:32 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Citius Pharmaceuticals, Inc. Stock Performance

Open
$0.70
Prev. Close
$0.68
Circuit Range
N/A
Day Range
$0.70 - $0.70
Year Range
$0.48 - $2.15
Volume
274
Average Traded
$0.70

Citius Pharmaceuticals, Inc. Share Price Today

As of 11 August 2026, Citius Pharmaceuticals, Inc.'s share price is $0.68. The stock opened at $0.70, compared to its previous close of $0.68. During today's trading session, Citius Pharmaceuticals, Inc.'s share price traded between $0.70 and $0.70, with an average price of $0.70. Over the past 52 weeks, the stock has recorded a high of $2.15 and a low of $0.48. In terms of performance, Citius Pharmaceuticals, Inc.'s share price has declined by 6.68% over the last six months and is down 48.18% on a year-on-year basis.

Citius Pharmaceuticals, Inc. Share Price Chart

$0.70$0.70
L
Show Current Price
H

Citius Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Dec 2024Mar 2025Jun 2025Dec 2025
RevenueN/AN/AN/AN/AN/A$3.94M
Net Profit-$8.54M-$10.57M-$10.28M-$11.51M-$9.20M-$9.39M
Net Profit MarginN/AN/AN/AN/AN/A-238.18%
Income ChangeN/A-23.75%2.76%-11.97%20.05%-2.06%

Citius Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars20222023
RevenueN/AN/A
Net Profit-$33.64M-$32.54M
Net Profit MarginN/AN/A
Income ChangeN/A3.26%

About Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections; and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. The Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido completed. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.

Citius Pharmaceuticals, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$0.59
$0.70
+22.11%
Jul 2026
$0.62
$0.57
-2.40%
Jun 2026
$0.63
$0.58
-12.05%
May 2026
$0.69
$0.66
-3.07%
Apr 2026
$0.85
$0.69
-24.64%
Mar 2026
$0.72
$0.91
+24.01%
Feb 2026
$0.74
$0.73
-1.08%
Jan 2026
$0.79
$0.74
-3.14%
Dec 2025
$1.39
$0.77
-46.50%
Nov 2025
$1.58
$1.43
-8.33%
Oct 2025
$1.25
$1.56
+26.83%
Sep 2025
$1.30
$1.23
-6.82%

CTXR Share Price FAQs

What is Citius Pharmaceuticals, Inc. share price today?

chevron-up
Citius Pharmaceuticals, Inc. share price today is $0.68 as on August 10, 2026 at 9:32 pm IST.

What is the 52 week high and 52 week low of Citius Pharmaceuticals, Inc. stock?

chevron-up
The 52 week high of Citius Pharmaceuticals, Inc. stock is $2.15, while the 52 week low is $0.48 as of 10 Aug '26.

What is CTXR's net income for the last quarter?

chevron-up
CTXR's net income for the last quarter is -0.01B USD.

What is the 5 year returns of CTXR?

chevron-up
The 5 year returns of CTXR is -98.78% as on 10 Aug '26.

What is the high & low stock price of CTXR today?

chevron-up
CTXR stock price hit a high of $0.70 and low of $0.70 as of 10 Aug '26.

Can I buy CTXR shares in India?

chevron-up
Yes. You can buy CTXR in India by opening an international trading account.